Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation. [electronic resource]
Producer: 20111128Description: 1280-1287 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Antineoplastic Agents -- adverse effects
- Carcinoma
- Chemoradiotherapy
- Epistaxis -- chemically induced
- Female
- Hematemesis -- chemically induced
- Hemoptysis -- chemically induced
- Humans
- Indoles -- adverse effects
- Male
- Middle Aged
- Nasopharyngeal Carcinoma
- Nasopharyngeal Neoplasms -- therapy
- Pyrroles -- adverse effects
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
- Sunitinib
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.